About

Training

Dr. Mansukhani qualified in medicine from M.G.M. Medical College, Navi Mumbai, in 2004, with a distinction in ophthalmology. Her first surgical post was a housemanship in plastic and vascular surgery: tissue handling and flap work that carries directly into breast reconstruction years later. She completed her DNB in General Surgery in 2012, having trained at Lilavati Hospital and Research Centre in Mumbai.

She then spent four years in Lilavati’s Department of Surgical Oncology under its chairman, Dr. P. Jagannath, first as a resident trainee, later as a junior consultant. The unit operated on cancers of the pancreas, liver and bile ducts: the procedures where margins, lymph nodes and the order of treatment decide what happens next.

That period produced her published research. Her papers, written under Dr. Jagannath, examined how to predict infection after major pancreatic surgery, when a smaller operation can safely replace a Whipple procedure, and how an inflammatory condition can convincingly imitate bile duct cancer.

She became a Member of the Royal College of Surgeons of Edinburgh in 2015, obtained the Fellowship of Minimal Access Surgery in 2017, and passed the Dubai Health Authority examination the same year.

Breast surgery

More than 200 breast operations performed independently during a four-year tenure in a dedicated breast surgical unit. Her declared special interest is in breast oncoplastic surgery, minimally invasive breast surgery and robotic breast surgery, approaches concerned with removing disease completely while leaving a breast a woman can live with afterwards.

In practice that spans the whole range: the lump that turns out to be a fibroadenoma, the screening recall that resolves after a biopsy, and the cancer that needs surgery, reconstruction and a plan agreed with an oncologist before anything begins.

Practice

She has practised in Dubai since 2017, first at NMC Royal Hospital and, since September 2018, at Prime Hospital in Al Garhoud. Alongside breast work she treats thyroid and endocrine conditions and performs general and laparoscopic surgery.

She initiated and established Prime Hospital’s multidisciplinary tumour board, the meeting where a surgeon, an oncologist, a radiologist and a pathologist agree a treatment plan together rather than in sequence. For a patient it means the plan has been argued over by four specialties before it is put to them.

Keeping current

Breast surgery has changed substantially in the past decade, and in 2026 she trained in robotic surgical skills at Orsi Academy in Belgium, in robotic breast oncoplastic surgery at IERBS in Taiwan, and in oncoplastic surgery and breast reconstruction with the Sociedade Brasileira de Mastologia. She became an active member of the American Society of Breast Surgeons in September 2026.

Approach

Surgical oncology training leaves a mark on how a surgeon thinks. In complex cancer surgery the operation is never the whole plan. It is one move within a sequence, and judging what to remove, when to operate and when to wait is the substance of the work.